Cerebrospinal fluid markers of prion diseases

被引:0
|
作者
Golanska, Ewa [1 ]
Gresner, Sylwia [1 ]
Sieruta, Monika [1 ]
Liberski, Powel [1 ]
机构
[1] Uniwersytet Medyczny Lodzi, Zaklad Patol Mol & Neuropatol, PL-92216 Lodz, Poland
关键词
Creutzfeldt-Jakob disease; 14-3-3; protein; biochemical markers; cerebrospinal fluid; diagnostic tests;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are no non-invasive tests allowing for definite premortem diagnosis of Creutzfeldt-Jakob disease (CJD). The paper presents the Current knowledge about laboratory tests supporting CJD diagnosis. 14-3-3 protein in the cerebrospinal fluid Is the only biochemical marker included in the diagnostic criteria for CJD approved by WHO. However, the test for 14-3-3 protein is useful Only when considered in an appropriate clinical context, together with other diagnostic criteria. In the paper we also present current research In the use of other proteins detected in the cerebrospinal fluid (tau, S100b, neuron-specific enolase, transthyretin, and beta-amyloid(1-42) as potential diagnostic markers. We discuss advantages and drawbacks of these markers.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 50 条
  • [41] Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie
    Llorens, Franc
    Barrio, Tomas
    Correia, Angela
    Villar-Pique, Anna
    Thuene, Katrin
    Lange, Peter
    Jose Badiola, Juan
    Schmitz, Matthias
    Lachmann, Ingolf
    Bolea, Rosa
    Zerr, Inga
    MOLECULAR NEUROBIOLOGY, 2018, 55 (11) : 8586 - 8591
  • [42] Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
    Sonia M. Vallabh
    Eric Vallabh Minikel
    Victoria J. Williams
    Becky C. Carlyle
    Alison J. McManus
    Chase D. Wennick
    Anna Bolling
    Bianca A. Trombetta
    David Urick
    Chloe K. Nobuhara
    Jessica Gerber
    Holly Duddy
    Ingolf Lachmann
    Christiane Stehmann
    Steven J. Collins
    Kaj Blennow
    Henrik Zetterberg
    Steven E. Arnold
    BMC Medicine, 18
  • [43] Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
    Seino, Yusuke
    Nakamura, Takumi
    Kawarabayashi, Takeshi
    Hirohata, Mie
    Narita, Sakiko
    Wakasaya, Yasuhito
    Kaito, Kozue
    Ueda, Tetsuya
    Harigaya, Yasuo
    Shoji, Mikio
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (01) : 395 - 404
  • [44] Proteinase inhibitors in the cerebrospinal fluid in neurological diseases
    L. V. Brylev
    Neurochemical Journal, 2009, 3 : 214 - 220
  • [45] Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases
    Kolmakova, T. S.
    Smirnova, O. B.
    Belyakova, E. I.
    NEUROCHEMICAL JOURNAL, 2010, 4 (01) : 41 - 45
  • [46] Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases
    T. S. Kolmakova
    O. B. Smirnova
    E. I. Belyakova
    Neurochemical Journal, 2010, 4 : 41 - 45
  • [47] Proteinase Inhibitors in the Cerebrospinal Fluid in Neurological Diseases
    Brylev, L. V.
    NEUROCHEMICAL JOURNAL, 2009, 3 (03) : 214 - 220
  • [48] Cerebrospinal fluid biomarkers in neurological diseases in children
    Shahim, Pashtun
    Mansson, Jan-Eric
    Darin, Niklas
    Zetterberg, Henrik
    Mattsson, Niklas
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 7 - 13
  • [49] The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture
    Satoh, J
    Kurohara, K
    Yukitake, M
    Kuroda, Y
    EUROPEAN NEUROLOGY, 1999, 41 (04) : 216 - 225
  • [50] The genetics of prion diseases
    Mastrianni, James A.
    GENETICS IN MEDICINE, 2010, 12 (04) : 187 - 195